Regulation of energy expenditure by estradiol in premenopausal women

Journal of Applied Physiology

Volumn 119, Issue 9, 2015, Pages 975-981

  Melanson, Edward L ^a,b,c   Gavin, Kathleen M ^b,c   Shea, Karen L ^b,c   Wolfe, Pamela ^b   Wierman, Margaret E ^a,c   Schwartz, Robert S ^b,c   Kohrt, Wendy M ^b,c  

^a and Diabetes ^*  (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Estradiol; Gonadotropin releasing hormone; Premenopausal women; Resistance exercise; Room calorimetry

Indexed keywords

ESTRADIOL; GONADORELIN; LEUPRORELIN;

ADULT; AGONISTS; BODY COMPOSITION; BONE DENSITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ENERGY METABOLISM; EXERCISE; FEMALE; HUMAN; MIDDLE AGED; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; YOUNG ADULT;

ADULT; BODY COMPOSITION; BONE DENSITY; DOUBLE-BLIND METHOD; ENERGY METABOLISM; ESTRADIOL; EXERCISE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; MIDDLE AGED; PREMENOPAUSE; RESISTANCE TRAINING; YOUNG ADULT;

EID: 84946134775     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00473.2015     Document Type: Article

References (44)

1. Bisdee JT, James WP, Shaw MA. Changes in energy expenditure during the menstrual cycle. Br J Nutr 61:187-199, 1989.
2. Bloesch D, Schutz Y, Breitenstein E, Jequier E, Felber JP. Thermogenic response to an oral glucose load in man: comparison between young and elderly subjects. J Am Coll Nutr 7:471-483, 1988.
3. Day DS, Gozansky WS, Bell C, Kohrt WM. Acute sex hormone suppression reduces skeletal muscle sympathetic nerve activity. Clin Auton Res 21:339-345, 2011.
4. Day DS, Gozansky WS, Van Pelt RE, Schwartz RS, Kohrt WM. Sex hormone suppression reduces resting energy expenditure and α-adrenergic support of resting energy expenditure. J Clin Endocrinol Metab 90:3312-3317, 2005.
5. Douchi T, Kuwahata R, Yamasaki H, Yamamoto S, Oki T, Nakae M, Nagata Y. Inverse relationship between the changes in trunk lean and fat mass during gonadotropin-releasing hormone agonist therapy. Maturitas 42:31-35, 2002.
6. Douchi T, Kuwahata T, Yoshimitsu N, Iwamoto I, Yamasaki H, Nagata Y. Changes in serum leptin levels during GnRH agonist therapy. Endocr J 50:355-359, 2003.
7. Dumesic DA, Abbott DH, Eisner JR, Herrmann RR, Reed JE, Welch TJ, Jensen MD. Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. Fertil Steril 70:94-101, 1998.
8. Espeland MA, Stefanick ML, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK, Greendale GA. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 82:1549-1556, 1997.
9. Ettinger B, Selby J, Citron JT, Vangessel A, Ettinger VM, Hendrickson MR. Cyclic hormone replacement therapy using quarterly progestin. Obstet Gynecol 83:693-700, 1994.
10. 10a. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 285:2486-2497, 2001.
11. Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Genazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 39:125-132, 2001.
12. Gorzek JF, Hendrickson KC, Forstner JP, Rixen JL, Moran AL, Lowe DA. Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. Med Sci Sports Exerc 39:248-256, 2007.
13. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-knockout mice. Proc Natl Acad Sci U S A 97:12729-12734, 2000.
14. Heymsfield SB, Gallagher D, Wang Z. Body composition modeling. Application to exploration of the resting energy expenditure fat-free mass relationship. Ann N Y Acad Sci 904:290-297, 2000.
15. Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B, Brot C, Kolthoff N, Sorensen OH, Beck-Nielsen H, Nielsen SP, Charles P, Mosekilde L. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 18:333-342, 2003.
16. Jequier E, Acheson K, Schutz Y. Assessment of energy expenditure and fuel utilization in man. Ann Rev Nutr 7:187-208, 1987.
17. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9, 2003.
18. Kohrt WM, Ehsani AA, Birge SJ Jr. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J Appl Physiol 84:1506-1512, 1998.
19. Kravitz HM, Zhao X, Bromberger JT, Gold EB, Hall MH, Matthews KA, Sowers MR. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 31:979-990, 2008.
20. Kristensen K, Pedersen SB, Vestergaard P, Mosekilde L, Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 163:55-62, 1999.
21. Lovejoy JC, Champagne CM, De Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 32:949-958, 2008.
22. Matsuo T, Saitoh S, Suzuki M. Effects of the menstrual cycle on excess postexercise oxygen consumption in healthy young women. Metabolism 48:275-277, 1999.
23. Meijer GA, Westerterp KR, Saris WH, Ten Hoor F. Sleeping metabolic rate in relation to body composition and the menstrual cycle. Am J Clin Nutr 55:637-640, 1992.
24. Melanson EL, Ingebrigtsen JP, Bergouignan A, Ohkawara K, Kohrt WM, Lighton JR. A new approach for flow-through respirometry measurements in humans. Am J Physiol Regul Integr Comp Physiol 298:R1571-R1579, 2010.
25. Mitsushima D, Takase K, Funabashi T, Kimura F. Gonadal steroids maintain 24 h acetylcholine release in the hippocampus: organizational and activational effects in behaving rats. J Neurol 29:3808-3815, 2009.
26. Nowicki M, Adamkiewicz G, Bryc W, Kokot F. The influence of luteinizing hormone-releasing hormone analog on serum leptin and body composition in women with solitary uterine myoma. Am J Obstet Gynecol 186:340-344, 2002.
27. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, Rudling M, Lindberg MK, Warner M, Angelin B, Gustafsson JA. Obesity and disturbed lipoprotein profile in estrogen receptor-deficient male mice. Biochem Biophys Res Commun 278:640-645, 2000.
28. Pasquali R, Casimirri F, Labate AM, Tortelli O, Pascal G, Anconetani B, Gatto MR, Flamia R, Capelli M, Barbara L. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord 18:614-621, 1994.
29. Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 288:191-197, 2001.
30. Pighon A, Barsalani R, Yasari S, Prud'homme D, Lavoie JM. Does exercise training prior to ovariectomy protect against liver and adipocyte fat accumulation in rats? Climacteric 13:238-248, 2010.
31. Pighon A, Gutkowska J, Jankowski M, Rabasa-Lhoret R, Lavoie JM. Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metabolism 60:629-639, 2011.
32. Revilla R, Revilla M, Villa LF, Cortes J, Arribas I, Rico H. Changes in body composition in women treated with gonadotropin-releasing hormone agonists. Maturitas 31:63-68, 1998.
33. Rogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150:2161-2168, 2009.
34. Shea KS, Gavin KM, Melanson EL, Gibbons E, Stavros A, Wolfe P, Kittleson J, Vondracek S, Gozansky WS, Schwartz RS, Wierman ME, Kohrt WM. Body composition and bone mineral density after ovarian hormone suppression with and without estradiol add-back. Menopause. In press.
35. Solomon SJ, Kurzer MS, Calloway DH. Menstrual cycle and basal metabolic rate in women. Am J Clin Nutr 36:611-616, 1982.
36. Utian WH, Gass ML, Pickar JH. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. Menopause 11:306-314, 2004.
37. Wade GN, Gray JM, Bartness TJ. Gonadal influences on adiposity. Int J Obes 9 Suppl 1:83-92, 1985.
38. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9, 1949.
39. Williams DB, Voigt BJ, Fu YS, Schoenfeld MJ, Judd HL. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement. Obstet Gynecol 84:787-793, 1994.
40. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 151:97-102, 1991.
41. Witte MM, Resuehr D, Chandler AR, Mehle AK, Overton JM. Female mice and rats exhibit species-specific metabolic and behavioral responses to ovariectomy. Gen Comp Endocrinol 166:520-528, 2010.
42. Wohlers LM, Spangenburg EE. 17Beta-estradiol supplementation attenuates ovariectomy-induced increases in ATGL signaling and reduced perilipin expression in visceral adipose tissue. J Cell Biochem 110:420-427, 2010.
43. Xu Y, Nedungadi TP, Zhu L, Sobhani N, Irani BG, Davis KE, Zhang X, Zou F, Gent LM, Hahner LD, Khan SA, Elias CF, Elmquist JK, Clegg DJ. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell metabolism 14:453-465, 2011.
44. Yamasaki H, Douchi T, Yamamoto S, Oki T, Kuwahata R, Nagata Y. Body fat distribution and body composition during GnRH agonist therapy. Obstet Gynecol 97:338-342, 2001.